Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Health Canada states 6 months to 2 years for Din
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(83)
•••
Comment by HaulJockeyon Oct 19, 2021 12:56pm
99 Views
Post# 34023142

RE:Health Canada states 6 months to 2 years for Din

RE:Health Canada states 6 months to 2 years for DinImagine, 6 months to 2 years for something that comes from a harmless plant that has been smoked for centuries, yet we mandate an experimental vaccine in less than a year to the entire population of the planet. Even now, less than 2 years old and we're giving it to 5 year olds. So if the vaccine works why isn't it working and why are we giving it to 5 year olds?

SamV21 wrote: Remember this is a narcotic Health Canada will want to be sure of safety and results approval ,If it is approved at all , no one knows ,not me , not you , not even Guy , hopefully it happens but I wouldn't hold my breath, and don't scare people into buying  by  saying buy and wake up rich one day. Wait for results.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities